News

Parkinson’s Patient, After Nerve Cell Transplant, Showed ‘Major’ Benefits for Nearly 25 Years

Lund University researchers followed a Parkinson’s disease patient who had undergone neuronal transplantation, and reported the patient experienced long-term “major clinical benefits,” including the restoration of normal dopamine function. Importantly, transplant-derived cell reinnervation was evident for almost 25 years, although the disease again began to progress some 14 years after transplantation. The study, “…

New Gut Model to Advance Research of Gut-Brain Interactions

An article from Nature Communications detailed validation for a new gut model called HuMiX, allowing the study of interactions between nutrients, human intestinal cells and bacteria. The close mimicking of intestinal conditions will allow further exploration of the impact of gut microbiome on the onset of Parkinson’s disease…

Overactive Innate Immune System Seen as Underlying Cause of Neuronal Death in Parkinson’s

Chronic activation of the innate immune system, the body’s first line of defense, is the main cause of a range of symptoms common to neurodegenerative diseases including dementia, an impairment often found in Parkinson’s disease patients, researchers from the University of Adelaide reported. The possibly important study, “The Enemy within: Innate…

Senior Helpers Now Offering In-Home Training Program for Parkinson’s Disease Caregivers

Senior Helpers has launched its Parkinson’s Care Program, developed together with specialists from the National Parkinson Foundation’s Center of Excellence, to provide caregivers the specialized training and certification needed to create individualized care plans for people with Parkinson’s disease. “Parkinson’s disease is a chronic and progressive movement disorder that affects nearly one million…

Common Parkinson’s Mutation Found to Enhance Key Gene Involved in Disease Progression

A specific mutation commonly found in Parkinson’s patients has been shown to enhance the expression of α-synuclein (SNCA), a key gene involved in the pathogenesis of Parkinson’s disease. These findings were published in Nature, in the study “Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression.” Genome-wide association studies…

Trequant Launches a Wearable, Watch-like Device to Monitor Tremors

Trequant, Inc., a wearable device startup, is launching a Kickstarter campaign to raise money to market and further develop its tremor quantifying device. The Trequant wearable is designed to appear and feel like a normal analog watch, but contains advanced sensors that monitor the extremity tremors common to movement disorders like Parkinson’s disease…

Suppressing Brain Immune Responses of Parkinson’s Patients Gives Promising Therapeutic Approach

Inhibitors of the JAK/STAT pathway may provide potential for treating patients with neurodegenerative diseases, particularly Parkinson’s, by reducing the degenerative inflammation in the brain according to the study “Inhibition of the JAK/STAT pathway protects against α-synuclein-induced neuroinflammation and dopaminergic neurodegeneration“, published May 4 in The…